Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amneal Pharmaceuticals, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AMRX
Nasdaq
2830
www.amneal.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amneal Pharmaceuticals, Inc.
What Amneal Pharmaceuticals (AMRX)'s Addition to the S&P 1000 Index Means For Shareholders
- Feb 12th, 2026 3:13 am
Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?
- Feb 9th, 2026 7:40 am
Is Amneal Pharmaceuticals (AMRX) a Great Value Stock Right Now?
- Feb 5th, 2026 7:40 am
3 Small-Cap Stocks That Fall Short
- Feb 4th, 2026 9:32 pm
3 Cash-Producing Stocks That Concern Us
- Feb 1st, 2026 9:40 pm
Is It Too Late To Consider Amneal Pharmaceuticals (AMRX) After Its Strong Multi‑Year Share Price Run?
- Jan 30th, 2026 10:11 am
Opioid Settlement And Index Inclusion Reframe Amneal Pharmaceuticals Risk And Reach
- Jan 30th, 2026 2:15 am
3 Healthcare Stocks We Steer Clear Of
- Jan 29th, 2026 9:34 pm
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
- Jan 28th, 2026 2:05 pm
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
- Jan 28th, 2026 10:10 am
TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
- Jan 27th, 2026 4:02 pm
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
- Jan 27th, 2026 6:00 am
2 Reasons to Sell AMRX and 1 Stock to Buy Instead
- Jan 25th, 2026 9:02 pm
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?
- Jan 22nd, 2026 7:40 am
3 Growth Companies With High Insider Ownership And Up To 79% Earnings Growth
- Jan 19th, 2026 4:35 am
Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?
- Jan 15th, 2026 7:40 am
Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025
- Jan 13th, 2026 7:04 pm
Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14
- Jan 10th, 2026 12:57 pm
KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease
- Jan 9th, 2026 9:00 am
Can This Healthcare Stock Keep Going After a Nearly 70% Surge?
- Jan 7th, 2026 12:55 pm
Scroll